Core Viewpoint - Lepu Medical experienced a stock price decline of 2.08% on September 26, with a trading price of 17.42 yuan per share and a total market capitalization of 32.76 billion yuan [1] Financial Performance - Lepu Medical's revenue for the first half of 2025 was 3.369 billion yuan, a year-on-year decrease of 0.43%, while the net profit attributable to shareholders was 691 million yuan, down 0.91% year-on-year [2] - The company has cumulatively distributed 4.957 billion yuan in dividends since its A-share listing, with 2.058 billion yuan distributed in the last three years [3] Stock Market Activity - The stock price of Lepu Medical has increased by 57.68% year-to-date, but it has seen a decline of 4.96% in the last five trading days and 7.59% over the past 20 days [1] - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 29.5585 million yuan on June 4 [1] Shareholder Structure - As of June 30, 2025, Lepu Medical had 100,100 shareholders, an increase of 6.18% from the previous period, with an average of 16,152 circulating shares per shareholder, down 5.82% [2] - Major shareholders include Huabao Zhongzheng Medical ETF and E Fund Growth Enterprise ETF, with changes in their holdings noted [3]
乐普医疗跌2.08%,成交额1.89亿元,主力资金净流出658.53万元